These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 8039537)

  • 1. The pharmacokinetics and pharmacodynamics of medifoxamine after oral administration in healthy elderly volunteers.
    Gainsborough N; Nelson ML; Maskrey V; Swift CG; Jackson SH
    Eur J Clin Pharmacol; 1994; 46(2):163-6. PubMed ID: 8039537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absolute bioavailability and pharmacokinetics of medifoxamine in healthy humans.
    Saleh S; Johnston A; Turner P
    Br J Clin Pharmacol; 1990 Oct; 30(4):621-4. PubMed ID: 2291875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tolerability and kinetics of intravenous medifoxamine in healthy volunteers.
    Saleh S; Johnston A; Edeki T; Turner P
    Int Clin Psychopharmacol; 1990 Apr; 5(2):97-102. PubMed ID: 2380545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and pharmacodynamics of adinazolam and N-desmethyladinazolam after oral and intravenous dosing in healthy young and elderly volunteers.
    Fleishaker JC; Hulst LK; Ekernäs SA; Grahnén A
    J Clin Psychopharmacol; 1992 Dec; 12(6):403-14. PubMed ID: 1474178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medifoxamine: oral tolerance and pharmacokinetic study in healthy human volunteers.
    Saleh S; Johnston A; Turner P
    Eur J Clin Pharmacol; 1990; 39(2):169-71. PubMed ID: 2253668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ocular hypotensive effects of medifoxamine.
    Saleh S; Turner P
    Br J Clin Pharmacol; 1992 Sep; 34(3):269-71. PubMed ID: 1389953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A placebo controlled double-blind evaluation of the pharmacodynamics of fengabine vs amitriptyline following single and multiple doses in elderly volunteers.
    Fairweather DB; Kerr JS; Hilton S; Hindmarch I
    Br J Clin Pharmacol; 1993 Mar; 35(3):278-83. PubMed ID: 8471403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacodynamics of milnacipran in young and elderly volunteers.
    Hindmarch I; Rigney U; Stanley N; Briley M
    Br J Clin Pharmacol; 2000 Feb; 49(2):118-25. PubMed ID: 10671905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adinazolam pharmacokinetics and behavioral effects following administration of 20-60 mg oral doses of its mesylate salt in healthy volunteers.
    Fleishaker JC; Phillips JP
    Psychopharmacology (Berl); 1989; 99(1):34-9. PubMed ID: 2506603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacology of adinazolam and N-desmethyladinazolam mesylate after single oral doses of each compound in healthy volunteers.
    Fleishaker JC; Friedman H; Pollock SR; Smith TC
    Clin Pharmacol Ther; 1990 Dec; 48(6):652-64. PubMed ID: 2249377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of repeated administration of cimetidine on the pharmacokinetics and pharmacodynamics of adinazolam in healthy subjects.
    Hulhoven R; Desager JP; Cox S; Harvengt C
    Eur J Clin Pharmacol; 1988; 35(1):59-64. PubMed ID: 3220095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple-dose pharmacokinetics and pharmacodynamics of adinazolam in elderly subjects.
    Fleishaker JC; Phillips JP; Smith TC; Smith RB
    Pharm Res; 1989 May; 6(5):379-86. PubMed ID: 2748528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single dose pharmacokinetics and pharmacodynamics of oral oxazepam in very elderly institutionalised subjects.
    Sonne J; Loft S; Døssing M; Boesgaard S; Andreasen F
    Br J Clin Pharmacol; 1991 Jun; 31(6):719-22. PubMed ID: 1867967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics and dynamics of intravenous adinazolam, N-desmethyl adinazolam, and alprazolam in healthy volunteers.
    Venkatakrishnan K; Culm KE; Ehrenberg BL; Harmatz JS; Corbett KE; Fleishaker JC; Greenblatt DJ
    J Clin Pharmacol; 2005 May; 45(5):529-37. PubMed ID: 15831776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of age, gender, and diurnal variation on the steady-state pharmacokinetics of BMS-181101, an antidepressant, in healthy subjects.
    Srinivas NR; Shyu WC; Gleason C; Schuster A; Greene DS; Barbhaiya RH
    Clin Pharmacol Ther; 1997 Oct; 62(4):408-16. PubMed ID: 9357392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probe of CYP3A by a single-point blood measurement after oral administration of midazolam in healthy elderly volunteers.
    Krupka E; Venisse N; Lafay C; Gendre D; Diquet B; Bouquet S; Perault MC
    Eur J Clin Pharmacol; 2006 Aug; 62(8):653-9. PubMed ID: 16832678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The lack of effect of smoking on the pharmacokinetics and pharmacodynamics of adinazolam and N-demethyladinazolam.
    Chambers JH; Fleishaker JC
    Biopharm Drug Dispos; 1994 May; 15(4):263-72. PubMed ID: 8068865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of duloxetine hydrochloride enteric-coated tablets in healthy Chinese volunteers: a randomized, open-label, single- and multiple-dose study.
    Zhao RK; Cheng G; Tang J; Song J; Peng WX
    Clin Ther; 2009 May; 31(5):1022-36. PubMed ID: 19539103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of the antidepressant rolipram in healthy volunteers.
    Krause W; Kühne G; Matthes H
    Xenobiotica; 1989 Jun; 19(6):683-92. PubMed ID: 2669364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and pharmacodynamics of alprazolam after oral and IV administration.
    Smith RB; Kroboth PD; Vanderlugt JT; Phillips JP; Juhl RP
    Psychopharmacology (Berl); 1984; 84(4):452-6. PubMed ID: 6152055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.